Trial NCT02031419

View at ClinicalTrials.gov 
Org. Study IDs: CC-122-DLBCL-001

Last trial update was posted on 2024-01-18

MeSH Interventions

Rituximab Spebrutinib

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse

Other Conditions


Stopping Reasons

Replaced with another clinical trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID